Jiuzhitang Co Ltd

SHE:000989 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#9826 Global
#2096 in China
Share Price
CN¥9.09
Change (1 day)
+0.33%
52-Week Range
CN¥7.60 - CN¥12.71
All Time High
CN¥21.14
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more

Jiuzhitang Co Ltd (000989) - Net Assets

Latest net assets as of September 2025: CN¥3.86 Billion CNY

Based on the latest financial reports, Jiuzhitang Co Ltd (000989) has net assets worth CN¥3.86 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.00 Billion) and total liabilities (CN¥1.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥3.86 Billion
% of Total Assets 77.23%
Annual Growth Rate 14.9%
5-Year Change 0.57%
10-Year Change 4.23%
Growth Volatility 49.93

Jiuzhitang Co Ltd - Net Assets Trend (1997–2024)

This chart illustrates how Jiuzhitang Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Jiuzhitang Co Ltd (1997–2024)

The table below shows the annual net assets of Jiuzhitang Co Ltd from 1997 to 2024.

Year Net Assets Change
2024-12-31 CN¥3.95 Billion +0.02%
2023-12-31 CN¥3.95 Billion -0.87%
2022-12-31 CN¥3.98 Billion +0.30%
2021-12-31 CN¥3.97 Billion +1.14%
2020-12-31 CN¥3.93 Billion -1.66%
2019-12-31 CN¥3.99 Billion -7.40%
2018-12-31 CN¥4.31 Billion -4.27%
2017-12-31 CN¥4.50 Billion +8.83%
2016-12-31 CN¥4.14 Billion +9.23%
2015-12-31 CN¥3.79 Billion +135.39%
2014-12-31 CN¥1.61 Billion +4.34%
2013-12-31 CN¥1.54 Billion +5.12%
2012-12-31 CN¥1.47 Billion +1.16%
2011-12-31 CN¥1.45 Billion +5.12%
2010-12-31 CN¥1.38 Billion +9.45%
2009-12-31 CN¥1.26 Billion +2.41%
2008-12-31 CN¥1.23 Billion +4.47%
2007-12-31 CN¥1.18 Billion +16.41%
2006-12-31 CN¥1.01 Billion -7.74%
2005-12-31 CN¥1.10 Billion -4.95%
2004-12-31 CN¥1.15 Billion +4.29%
2003-12-31 CN¥1.11 Billion +104.96%
2002-12-31 CN¥539.91 Million -0.80%
2001-12-31 CN¥544.27 Million +9.62%
2000-12-31 CN¥496.50 Million +214.33%
1999-12-31 CN¥157.96 Million +57.32%
1998-12-31 CN¥100.41 Million +8.04%
1997-12-31 CN¥92.93 Million --

Equity Component Analysis

This analysis shows how different components contribute to Jiuzhitang Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 97687369700.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥976.87 Million 26.03%
Common Stock CN¥855.94 Million 22.81%
Other Comprehensive Income CN¥448.52 Million 11.95%
Other Components CN¥1.47 Billion 39.22%
Total Equity CN¥3.75 Billion 100.00%

Jiuzhitang Co Ltd Competitors by Market Cap

The table below lists competitors of Jiuzhitang Co Ltd ranked by their market capitalization.

Company Market Cap
Shenzhen Consys Science & Technology Co. Ltd. A
SHG:688788
 		$545.81 Million
Vitesse Energy Inc
NYSE:VTS
 		$545.82 Million
Mainstreet Equity Corp
PINK:MEQYF
 		$545.85 Million
Antin Infrastructure Partners
LSE:0AA5
 		$545.92 Million
Dogan Sirketler Grubu Holding AS
IS:DOHOL
 		$545.61 Million
San Bian Science & Technology Co Ltd
SHE:002112
 		$545.59 Million
Draper Esprit plc
PINK:GRWXF
 		$545.34 Million
ZhuZhou QianJin Pharmaceutical Co Ltd
SHG:600479
 		$545.18 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiuzhitang Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 3,952,272,399 to 3,753,212,418, a change of -199,059,981 (-5.0%).
  • Net income of 216,202,230 contributed positively to equity growth.
  • Dividend payments of 338,612,805 reduced retained earnings.
  • Share repurchases of 76,208,579 reduced equity.
  • Other comprehensive income decreased equity by 20,280.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥216.20 Million +5.76%
Dividends Paid CN¥338.61 Million -9.02%
Share Repurchases CN¥76.21 Million -2.03%
Other Comprehensive Income CN¥-20.28K -0.0%
Other Changes CN¥-420.55K -0.01%
Total Change CN¥- -5.04%

Book Value vs Market Value Analysis

This analysis compares Jiuzhitang Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.06x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 31.72x to 2.06x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.29 CN¥9.09 x
1998-12-31 CN¥0.31 CN¥9.09 x
1999-12-31 CN¥0.49 CN¥9.09 x
2000-12-31 CN¥1.54 CN¥9.09 x
2001-12-31 CN¥1.55 CN¥9.09 x
2002-12-31 CN¥1.58 CN¥9.09 x
2003-12-31 CN¥3.35 CN¥9.09 x
2004-12-31 CN¥3.54 CN¥9.09 x
2005-12-31 CN¥3.37 CN¥9.09 x
2006-12-31 CN¥2.85 CN¥9.09 x
2007-12-31 CN¥3.44 CN¥9.09 x
2008-12-31 CN¥3.58 CN¥9.09 x
2009-12-31 CN¥3.69 CN¥9.09 x
2010-12-31 CN¥4.05 CN¥9.09 x
2011-12-31 CN¥4.25 CN¥9.09 x
2012-12-31 CN¥4.23 CN¥9.09 x
2013-12-31 CN¥4.53 CN¥9.09 x
2014-12-31 CN¥3.05 CN¥9.09 x
2015-12-31 CN¥7.16 CN¥9.09 x
2016-12-31 CN¥4.76 CN¥9.09 x
2017-12-31 CN¥5.18 CN¥9.09 x
2018-12-31 CN¥4.98 CN¥9.09 x
2019-12-31 CN¥4.75 CN¥9.09 x
2020-12-31 CN¥4.67 CN¥9.09 x
2021-12-31 CN¥4.64 CN¥9.09 x
2022-12-31 CN¥4.66 CN¥9.09 x
2023-12-31 CN¥4.62 CN¥9.09 x
2024-12-31 CN¥4.41 CN¥9.09 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiuzhitang Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 5.76%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.12%
  • • Asset Turnover: 0.46x
  • • Equity Multiplier: 1.39x
  • Recent ROE (5.76%) is below the historical average (11.80%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 20.40% 7.67% 0.87x 3.07x CN¥9.63 Million
1998 22.18% 7.15% 0.95x 3.26x CN¥12.18 Million
1999 19.98% 9.55% 0.88x 2.39x CN¥15.72 Million
2000 7.64% 8.32% 0.56x 1.64x CN¥-11.69 Million
2001 10.44% 7.38% 0.81x 1.74x CN¥2.19 Million
2002 12.34% 6.95% 0.89x 2.00x CN¥11.92 Million
2003 7.59% 8.06% 0.76x 1.24x CN¥-26.06 Million
2004 9.26% 10.35% 0.76x 1.17x CN¥-8.51 Million
2005 2.17% 2.24% 0.81x 1.20x CN¥-85.29 Million
2006 4.41% 4.71% 0.69x 1.36x CN¥-56.38 Million
2007 10.87% 12.48% 0.71x 1.23x CN¥10.25 Million
2008 16.28% 18.15% 0.71x 1.26x CN¥77.08 Million
2009 11.79% 13.37% 0.72x 1.23x CN¥22.57 Million
2010 11.80% 14.50% 0.65x 1.26x CN¥24.83 Million
2011 13.92% 17.76% 0.63x 1.24x CN¥56.86 Million
2012 7.61% 10.84% 0.56x 1.26x CN¥-35.02 Million
2013 23.62% 51.68% 0.37x 1.23x CN¥209.90 Million
2014 25.08% 50.57% 0.37x 1.34x CN¥242.50 Million
2015 12.44% 54.05% 0.19x 1.18x CN¥92.32 Million
2016 15.76% 24.38% 0.56x 1.16x CN¥238.16 Million
2017 16.03% 18.80% 0.65x 1.30x CN¥271.28 Million
2018 7.83% 10.64% 0.60x 1.22x CN¥-93.31 Million
2019 4.82% 6.04% 0.65x 1.23x CN¥-206.50 Million
2020 6.94% 7.65% 0.70x 1.29x CN¥-119.94 Million
2021 6.82% 7.15% 0.72x 1.33x CN¥-126.22 Million
2022 8.98% 11.80% 0.58x 1.31x CN¥-40.59 Million
2023 7.53% 10.04% 0.56x 1.35x CN¥-97.82 Million
2024 5.76% 9.12% 0.46x 1.39x CN¥-159.12 Million

Industry Comparison

This section compares Jiuzhitang Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $4,523,155,599
  • Average return on equity (ROE) among peers: -21.03%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Jiuzhitang Co Ltd (000989) CN¥3.86 Billion 20.40% 0.29x $545.65 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $52.15 Million 21.80% 0.58x $623.66 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $765.24 Million 1.30% 0.72x $325.92 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $78.32 Million 0.00% 1.98x $3.03 Billion
Wedge Industrial Co Ltd (000534) $1.24 Billion 8.20% 0.96x $1.75 Billion
Yunnan Baiyao Group Co Ltd (000538) $38.34 Billion 14.39% 0.44x $5.59 Billion
Hainan Haiyao Co Ltd (000566) $590.38 Million -258.34% 9.36x $713.60 Million
Tus Pharmaceutical Group Co Ltd (000590) $184.11 Million -46.59% 2.19x $317.60 Million
Northeast Pharmaceutical Group Co Ltd (000597) $1.57 Billion 22.73% 1.61x $426.40 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $2.06 Billion 23.61% 0.46x $2.04 Billion
Renhe Pharmacy Co Ltd (000650) $338.74 Million 2.59% 1.24x $777.45 Million